NorthSea Therapeutics' Series A Round

NorthSea Therapeutics raised a round of funding on December 12, 2017.

NorthSea Therapeutics is a biotech company focused on developing structurally engineered fatty acids ('SEFAs') for the treatment of inflammatory and liver diseases.…

Articles about NorthSea Therapeutics' Series A Round: